Capitolis Liquid Global Markets’s Boston Scientific BSX Stock Holding History

Capitolis Liquid Global Markets’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-147,333	Closed	-$9.25M	–	328
2026 Q1	$9.25M	Sell	147,333 -169,971	-54%	-$13.6M	0.06%	194
2025 Q4	$30.3M	Buy	317,304 +82,304	+35%	+$8.07M	0.18%	92
2025 Q3	$22.9M	Buy	235,000 +75,000	+47%	+$7.77M	0.18%	87
2025 Q2	$17.2M	Buy	+160,000	New	+$16.2M	0.13%	109

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capitolis Liquid Global Markets's BSX Position: Q2 2026 in Review

Capitolis Liquid Global Markets sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 147,333 shares — an estimated $9.25M sold.

Capitolis Liquid Global Markets first reported a position in BSX in Q2 2025 and held it in 4 quarters. The position peaked at $30.3M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Capitolis Liquid Global Markets reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Capitolis Liquid Global Markets sold 147,333 Boston Scientific shares in Q2 2026, an estimated $9.25M.
Capitolis Liquid Global Markets first reported a position in Boston Scientific in Q2 2025 and held it in 4 quarters.
Capitolis Liquid Global Markets's Boston Scientific position peaked at $30.3M in Q4 2025.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.